J Korean Neurol Assoc.
2016 Feb;34(1):41-44. 10.17340/jkna.2016.1.7.
A Recurrent Ischemic Stroke Stabilization after Using Non-Vitamin K Antagonist Oral Anticoagulant (NOAC)
- Affiliations
-
- 1Department of Neurology, Veterans Health Service Medical Center, Seoul, Korea. hippocam@naver.com
- KMID: 2153160
- DOI: http://doi.org/10.17340/jkna.2016.1.7
Abstract
- Current stroke guidelines recommend the administration of non-vitamin-K-antagonist oral anticoagulant (NOAC) for the prevention of cardioembolic stroke induced by nonvalvular atrial fibrillation. We report a patient who suffered from recurrent posterior circulation strokes-occurring eight times in 4 months-even under adequate antiplatelet medication. Changing the medication from antiplatelet agents to NOAC stopped the stroke recurrence. We suggest that NOAC has a role in the prevention of recurrent stroke of undetermined etiology in the posterior circulation.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Use of Non-Vitamin K Dependent Oral Anticoagulant in Ischemic Stroke
- Occurrence of Ischemic Stroke in Patients With Atrial Fibrillation Receiving Non-Vitamin K Oral Anticoagulants: Causes and Prevention Strategies
- The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes
- Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non‑vitamin K antagonist oral anticoagulants
- Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
